Thyroid cancer is the most common endocrine malignancy with almost one million people
living with thyroid cancer in the United States. Although early-stage well-differentiated …

Patients with thyroid cancer (TC) usually have an excellent prognosis; however, 5–10% of
them develop an advanced disease. The prognosis of this subgroup is still favourable if the …

Although the incidence of thyroid cancer is increasing year by year, most patients, especially
those with differentiated thyroid cancer, can usually be cured with surgery, radioactive …

Simple Summary Positron emission tomography (PET), typically combined with computed
tomography (CT) has become a critical advanced imaging technique in oncology. With PET …

Follicular thyroid carcinoma (FTC) is the second most common cancer of the thyroid gland,
accounting for up to 20% of all primary malignant tumors in iodine-replete areas. The …

Differentiated thyroid cancer (DTC) represents the most frequent endocrine neoplasm, with
an excellent prognosis [1]. After surgery, radioactive iodine (RAI) treatment remains a …

Simple Summary In patients with differentiated thyroid cancer, the standard treatment
consists in surgery followed by radioactive iodine (RAI) therapy. Follow-up is usually …

Differentiated thyroid cancer (DTC), arising from thyroid follicular epithelial cells, is the most
common type of thyroid cancer. Despite the well-known utilization of radioiodine treatment in …

Background: Patients with differentiated thyroid cancer (DTC) are referred to radioactive
131I (RAI) therapy and post-therapy 131I whole-body scintigraphy (WBS) to identify local …

Differentiated thyroid carcinoma (DTC) has been increasing in incidence in the United
States over the last several decades, although mortality rates have remained low …